Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products

Severe acute respiratory syndrome coronavirus 2 infected patients, receiving background anti-CD20 therapy, were treated with convalescent plasma or plasma-based products. Eight patients were included in the study, presenting with prolonged disease course and delayed viral clearance. CP/plasma-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenig, Ariel, Ishay, Yuval, Kharouf, Fadi, Rubin, Limor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024218/
https://www.ncbi.nlm.nih.gov/pubmed/33838340
http://dx.doi.org/10.1016/j.clim.2021.108723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024218/
https://www.ncbi.nlm.nih.gov/pubmed/33838340
http://dx.doi.org/10.1016/j.clim.2021.108723

Ejemplares similares